UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A DSC study of the NaNO3-KNO3 system using an innovative encapsulation technique

Thermochimica acta, 2010-09, Vol.509 (1-2), p.62-66

2010

Volltextzugriff (PDF)

The high-temperature heat capacity of the (Li, Na)F liquid solution

The Journal of chemical thermodynamics, 2009-08, Vol.41 (8), p.899-903

2009

Volltextzugriff (PDF)

A DSC study of the NaNO sub(3)-KNO sub(3) system using an innovative encapsulation technique

Thermochimica acta, 2010-09, Vol.509 (1-2), p.62-66

2010

Volltextzugriff (PDF)

A DSC study of the NaNO 3–KNO 3 system using an innovative encapsulation technique

Thermochimica acta, 2010, Vol.509 (1), p.62-66

2010

Volltextzugriff (PDF)

AFS Second Vice President Candidate Statement

Fisheries, 2022-03, Vol.47 (3), p.130-131

Dockendorf, Kevin J.

2022

Volltextzugriff (PDF)

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

Science translational medicine, 2016-11, Vol.8 (363), p.363ra150

2016

Volltextzugriff (PDF)

When do business groups embrace outside lobbying in trade policy? The case of the CPTPP in Chile

Estudos Internacionais, 2024-08, Vol.11 (2), p.7-23

2024

Volltextzugriff (PDF)

Digitally Enabled, Patient‐Centric Clinical Trials: Shifting the Drug Development Paradigm

Clinical and translational science, 2021-03, Vol.14 (2), p.445-459

2021

Volltextzugriff (PDF)

{ NCIFD } — An Internal R Package for a Fisheries Agency

Fisheries (Bethesda), 2023-10, Vol.48 (10), p.411-417

2023

Volltextzugriff (PDF)

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Journal of clinical pharmacology, 2020-09, Vol.60 (9), p.1157-1165

2020

Volltextzugriff (PDF)

Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults

Clinical and translational science, 2021-03, Vol.14 (2), p.599-605

2021

Volltextzugriff (PDF)

An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

The AAPS journal, 2022-05, Vol.24 (3), p.52-52, Article 52

2022

Volltextzugriff (PDF)

Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study

JMIR formative research, 2022-01, Vol.6 (1), p.e26276-e26276

2022

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of the β‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1 Inhibitor Verubecestat (MK‐8931) in Healthy Elderly Male and Female Subjects

Clinical and translational science, 2019-09, Vol.12 (5), p.545-555

2019

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Clinical pharmacology and therapeutics, 2019-05, Vol.105 (5), p.1234-1243

2019

Volltextzugriff (PDF)

Comparison of the influence of a Lewis acid AlCl3 and a Brønsted acid HCl on the organosolv pulping of beech wood

Green chemistry : an international journal and green chemistry resource : GC, 2014, Vol.16 (3), p.1569

2014

Volltextzugriff (PDF)

Data Visualization for Chronic Neurological and Mental Health Condition Self-management: Systematic Review of User Perspectives

JMIR mental health, 2022-04, Vol.9 (4), p.e25249-e25249

2022

Volltextzugriff (PDF)

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

Clinical and translational science, 2020-05, Vol.13 (3), p.462-472

2020

Volltextzugriff (PDF)

A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials

The AAPS journal, 2022-05, Vol.24 (3), p.53-53, Article 53

2022

Volltextzugriff (PDF)

Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study

Clinical pharmacology and therapeutics, 2019-01, Vol.105 (1), p.168-176

2019

Volltextzugriff (PDF)

Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects

Antiviral therapy, 2015-01, Vol.20 (4), p.397-405

2015

Volltextzugriff (PDF)

Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine

Journal of clinical pharmacy and therapeutics, 2020-10, Vol.45 (5), p.1098-1105

2020

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1450-1456

2009

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies

Cephalalgia reports, 2023-01, Vol.6

2023

Volltextzugriff (PDF)

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials

Cephalalgia reports, 2021, Vol.4

2021

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(38)
Technology
(25)
Humans
(17)
Pharmacology & Pharmacy
(15)
Engineering
(14)
Engineering, Electrical & Electronic
(12)
Telecommunications
(12)
Physical Sciences
(11)
Cognitive Radar
(10)
Pharmacokinetics
(10)
Power Amplifiers
(10)
Radar
(10)
Computer Science
(9)
Impedance
(9)
Neurology
(9)
Male
(8)
Algorithms
(7)
Endocrinology & Metabolism
(7)
Female
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A DSC study of the NaNO3-KNO3 system using an innovative encapsulation technique

The high-temperature heat capacity of the (Li, Na)F liquid solution

A DSC study of the NaNO sub(3)-KNO sub(3) system using an innovative encapsulation technique

A DSC study of the NaNO 3–KNO 3 system using an innovative encapsulation technique

AFS Second Vice President Candidate Statement

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

When do business groups embrace outside lobbying in trade policy? The case of the CPTPP in Chile

Digitally Enabled, Patient‐Centric Clinical Trials: Shifting the Drug Development Paradigm

{ NCIFD } — An Internal R Package for a Fisheries Agency

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults

An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments: Observational Study

Safety, Tolerability, and Pharmacokinetics of the β‐Site Amyloid Precursor Protein‐Cleaving Enzyme 1 Inhibitor Verubecestat (MK‐8931) in Healthy Elderly Male and Female Subjects

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Comparison of the influence of a Lewis acid AlCl3 and a Brønsted acid HCl on the organosolv pulping of beech wood

Data Visualization for Chronic Neurological and Mental Health Condition Self-management: Systematic Review of User Perspectives

Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males

A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials

Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study

Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects

Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials

Suchergebnisse filtern